E.coli-derived human PKC iota recombinant protein (Position: D21-Q214). Human PKC iota shares 96% and 97% amino acid (aa) sequence identity with mouse and rat PKC iota, respectively.
Conjugation:
Unconjugated
Alternative Names:
Protein kinase C iota type, 2.7.11.13, Atypical protein kinase C-lambda/iota, PRKC-lambda/iota, aPKC-lambda/iota, nPKC-iota, PRKCI, DXS1179E
PKC iota/PRKCI Rabbit Polyclonal Antibody
Clonality:
Polyclonal
Concentration:
Adding 0.2 ml of distilled water will yield a concentration of 500 µg/ml.
Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation
Form:
Lyophilized
Target:
Protein kinase C iota type
Application Dilute:
Immunohistochemistry (Paraffin-embedded Section), 0.5-1µg/ml, Human, Mouse, Rat Western blot, 0.1-0.5µg/ml, Human, Mouse, Rat
IHC(P) analysis of Mouse Brain Tissue using Anti-PKC iota Picoband antibody.
Anti-PKC iota Picoband antibody, Western blotting. All lanes: Anti PKC iota at 0.5 ug/ml. Lane 1: SHG Whole Cell Lysate at 40 ug. Lane 2: A549 Whole Cell Lysate at 40 ug. Lane 3: U87 Whole Cell Lysate at 40 ug. Lane 4: 293T Whole Cell Lysate at 40 ug. Lane 5: HELA Whole Cell Lysate at 40 ug. Lane 6: JURKAT Whole Cell Lysate at 40 ug. Predicted bind size: 68 KD. Observed bind size: 68 KD.
IHC(P) analysis of Rat Brain Tissue using Anti-PKC iota Picoband antibody.
Anti-PKC iota Picoband antibody, IHC(P): Human Lung Cancer Tissue.
